UBS Group’s Direxion Nanotechnology ETF TYNE Stock Holding History

UBS Group’s Portfolio TYNE Stock Details TYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,000	Closed	-$368K	–	11545
2022 Q3	$368K	Hold	25,000	–	–	﹤0.01%	4603
2022 Q2	$372K	Hold	25,000	–	–	﹤0.01%	4488
2022 Q1	$469K	Hold	25,000	–	–	﹤0.01%	4742
2021 Q4	$589K	Buy	+25,000	New	+$605K	﹤0.01%	4841

Other funds holding TYNE

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group's TYNE Position: Q4 2022 in Review

UBS Group sold out of Direxion Nanotechnology ETF (TYNE) in Q4 2022, closing a stake of 25,000 shares — an estimated $368K sold.

UBS Group first reported a position in TYNE in Q4 2021 and held it in 4 quarters. The position peaked at $589K in Q4 2021. 1 fund tracked by Wall St. Rank holds TYNE as of Q4 2022.

UBS Group reported no remaining Direxion Nanotechnology ETF position as of Q4 2022 after selling out during the quarter.
UBS Group sold 25,000 Direxion Nanotechnology ETF shares in Q4 2022, an estimated $368K.
UBS Group first reported a position in Direxion Nanotechnology ETF in Q4 2021 and held it in 4 quarters.
UBS Group's Direxion Nanotechnology ETF position peaked at $589K in Q4 2021.
1 fund tracked by Wall St. Rank held Direxion Nanotechnology ETF as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.